Stock BDX BECTON, DICKINSON AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Becton, Dickinson and Company Wiener Boerse

Equities

BDX

US0758871091

End-of-day quote Wiener Boerse
Other stock markets
 03:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
218.1 EUR -0.64% Intraday chart for Becton, Dickinson and Company +0.88% -0.86%
03/05 TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 MT
02/05 Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280 MT

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

Weaknesses

  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.19 times its estimated earnings per share for the ongoing year.
  • The company's enterprise value to sales, at 3.97 times its current sales, is high.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-0.86% 67.8B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
C+
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
C
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
B-
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
A-
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
A-
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-0.03% 25B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BDX Stock
  4. BDX Stock
  5. Ratings Becton, Dickinson and Company